p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: Its relationship with differentiation

Journal of Pathology

Volumn 179, Issue 3, 1996, Pages 248-253

  Doglioni, Claudio ^a   Pelosio, Paola ^b   Laurino, Licia ^b   Macri, Ettore ^a   Meggiolaro, Enzo ^a   Favretti, Franco ^a   Barbareschi, Mattia ^c  

^a Hospital of Belluno   (Italy)

^b City Hospital of Feltre   (Italy)

^c SANTA CHIARA HOSPITAL   (Italy)

Author keywords

colon; cyclin dependent inhibitor; differentiation; human; immunohistochemistry; neoplasm; p21; p53; proliferation

Indexed keywords

PROTEIN P53;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLON ADENOMA; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA; CELL DIFFERENTIATION; CELL DIVISION; COLON; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; NEOPLASM PROTEINS; PROTEIN KINASE INHIBITORS;

EID: 0029791681     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199607)179:3<248::AID-PATH571>3.0.CO;2-6     Document Type: Article

References (30)

1. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
2. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
3. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Clonation of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211: 90-98.
4. El-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53 mediated G1 arrest and apoptosis. Cancer Res 1994; 54: 1169-1174.
5. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R. Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701-707.
6. Michieli P, Chedid M. Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994; 54: 3391-3395.
7. Johnson M, Dimitrov D. Vojta PJ, et al. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 mRNA in human cells. Mol Carcinogenesis 1994; 11: 59-64.
8. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994; 9: 3397-3406.
9. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini MEE. Induction of p21 (WAF1/CIP1) during differentiation. Oncogene 1994; 9: 3389-3396.
10. Halevy O, Novitch BG, Spicer DB, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995: 267: 1018-1021.
11. Zhang W, Grasso L, McClain GD, et al. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 1995; 55: 668-674.
12. Parker SB, Eichele G, Zhang P, et al. p53-independent expression of p21/CIP1 in muscle and other terminally differentiating cells. Science 1995; 267: 1024-1027.
13. Marchetti A, Doglioni C, Barbareschi M, et al. p21 RNA and protein expression in non-small cell lung cancer: evidence of p53-independent expression and association with tumoral differentiation. Oncogene 1996; 12: 1319-1324.
14. El-Deiry WS, Tokino T, Waldman T, et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995; 55: 2910-2919.
15. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139: 1131-1134.
16. Dei Tos AP, Doglioni C, Barbareschi M, Laurino L, Fletcher CDM. p53 expression in soft tissue lesions. Histopathology 1993: 22: 45-50.
17. Barbareschi M, Girlando S, Mauri MF, et al. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol 1994; 102: 171-175.
18. Johnston PG, O'Brien MJ, Dervan PA, Carney DN. Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas and normal mucosa. Hum Pathol 1989; 20: 696-700.
19. Levine DS, Haggitt RC. Colon. In: Sternberg SS, ed. Histology for Pathologists. New York: Raven Press, 1992.
20. Chen J, Jackson PK, Kirshner MW, Dutta A. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 1995; 374: 386-388.
21. Lawson MJ, White LM, Coyle P, et al. An assessment of proliferative and enzyme activity in transitional mucosa adjacent to colonie cancer. Cancer 1989; 64: 1061-1066.
22. Deschner EE, Lipkin M, Solomon C. Study of human rectal epithelial cells in vitro - II. H3 thymidine incorporation into polyps and adjacent mucosa. J Nail Cancer Inst 1966; 36: 849-857.
23. Deschner EE, Lipkin M. Study of human rectal epithelial cells in vitro - III. RNA, protein and DNA synthesis in polyps and adjacent mucosa. J Natl Cancer Inst 1970; 44: 175-185.
24. Hague A, Moorghen M, Hicks D, Chapman M, Paraskeva C. BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene 1994; 9: 3367-3370.
25. Marchetti A, Buttitta F, Pellegrini S, Lori A. Bertacca G, Bevilacqua G. Absence of somatic mutations in the coding region of the WAF1/CIP1 gene in human breast, lung and ovarian carcinomas: a polymorphism at codon 31. Int J Oncol 1995; 6: 187-189.
26. Li Y, Laurentpuig P, Salmon RJ, Thomas G, Hamelin R. Polymorphism and probable lack of mutation in the WAF1/CIP1 gene in colorectal cancer. Oncogene 1995; 10: 599-601.
27. Dix B, Robbins P, Carello S, House A, Iacopetta B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 1994; 70: 585-590.
28. Fuchs B, O'Connor D, Fallis L, Schedtmann KH, Lu X. p53 phosphorylation mutants retain transcriptional activity. Oncogene 1995; 10: 789-793.
29. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995; 92: 5545-5549.
30. Sheng HM, Reisman D, Thompson EA, Beauchamp RD. Transforming growth factor β inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 1995; 10: 177-184.